{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:22:22Z","timestamp":1788931342053,"version":"build-2803163510"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Endocrine deficiencies, including hypothalamic-pituitary-gonadal axis (HPGA) impairment, are common in survivors of childhood and adolescent medulloblastoma. Still, data regarding pubertal development and fecundity are limited, and few studies assessed HPGA function in males. We aimed to describe HPGA function in a large cohort of patients with medulloblastoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study comprising all 62 medulloblastoma patients treated in our center between 1987 and 2021, who were at least 2\u00a0years from completion of therapy. HPGA function was assessed based on clinical data, biochemical markers, and questionnaires.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 76% of female patients had clinical or biochemical evidence of HPGA dysfunction. Biochemical evidence of diminished ovarian reserve was seen in all prepubertal girls (n\u00a0=\u00a04). Among the males, 34% had clinical or biochemical evidence of gonadal dysfunction, 34% had normal function, and 29% were age-appropriately clinically and biochemically prepubertal. The difference between males and females was significant (P\u00a0=\u00a0.003). Cyclophosphamide-equivalent dose was significantly associated with HPGA function in females, but not in males. There was no association between HPGA dysfunction and other endocrine deficiencies, length of follow-up, weight status, and radiation treatment protocol. Two female and 2 male patients achieved successful pregnancies, resulting in 6 live births.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HPGA dysfunction is common after treatment for childhood medulloblastoma. This is seen more in females, likely due to damage to the ovaries from spinal radiotherapy. Our findings may assist in counseling patients and their families regarding risk to future fertility and need for fertility preservation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noad009","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T14:53:51Z","timestamp":1673535231000},"page":"1345-1354","source":"Crossref","is-referenced-by-count":15,"title":["Hypothalamic-pituitary-gonadal function, pubertal development, and fertility outcomes in male and female medulloblastoma survivors: a single-center experience"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9716-3177","authenticated-orcid":false,"given":"Eve","family":"Stern","sequence":"first","affiliation":[{"name":"Pediatric Endocrinology and Diabetes Unit, The Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center , Ramat-Gan , Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Ben-Ami","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology and Diabetes Unit, The Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center , Ramat-Gan , Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah\u00a0","family":"Gruber","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology and Diabetes Unit, The Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center , Ramat-Gan , Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Toren","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"},{"name":"Division of Pediatric Hematology-Oncology, The Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center , Ramat-Gan , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shani","family":"Caspi","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"},{"name":"Division of Pediatric Hematology-Oncology, The Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center , Ramat-Gan , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gadi","family":"Abebe-Campino","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"},{"name":"Division of Pediatric Hematology-Oncology, The Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center , Ramat-Gan , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Lurye","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology-Oncology, The Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center , Ramat-Gan , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Yalon","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"},{"name":"Division of Pediatric Hematology-Oncology, The Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center , Ramat-Gan , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalit","family":"Modan-Moses","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology and Diabetes Unit, The Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center , Ramat-Gan , Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"issue":"9","key":"2023070706524153600_CIT0001","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.18.00969","article-title":"Late morbidity and mortality among medulloblastoma survivors diagnosed across three decades: a report from the childhood cancer survivor study","volume":"37","author":"Salloum","year":"2019","journal-title":"Am J Clin Oncol."},{"issue":"6","key":"2023070706524153600_CIT0002","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3171\/jns.1979.50.6.0721","article-title":"Chemotherapy as an adjunct in the initial management of cerebellar medulloblastomas. A\u00a0preliminary report","volume":"50","author":"Venes","year":"1979","journal-title":"J Neurosurg."},{"issue":"2","key":"2023070706524153600_CIT0003","first-page":"107","article-title":"Multidisciplinary treatment of medulloblastoma: a 5-year experience with the SIOP trial","volume":"8","author":"Gerosa","year":"1981","journal-title":"Child\u2019s Brain."},{"issue":"6","key":"2023070706524153600_CIT0004","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jpeds.2010.11.019","article-title":"Inhibin B and anti-M\u00fcllerian hormone as markers of gonadal function after treatment for medulloblastoma or posterior fossa ependymoma during childhood","volume":"158","author":"Cuny","year":"2011","journal-title":"J Pediatr."},{"issue":"6","key":"2023070706524153600_CIT0005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/neuonc\/nor025","article-title":"Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology","volume":"13","author":"von\u00a0Bueren","year":"2011","journal-title":"Neuro Oncol"},{"issue":"12","key":"2023070706524153600_CIT0006","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00381-019-04402-x","article-title":"Childhood medulloblastoma-a single institution\u2019s historical perspective on survival and functional morbidity","volume":"35","author":"Phipps","year":"2019","journal-title":"Childs Nerv Syst."},{"issue":"2","key":"2023070706524153600_CIT0007","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/pbc.25291","article-title":"Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue","volume":"62","author":"Balachandar","year":"2015","journal-title":"Pediatric Cancer"},{"issue":"1","key":"2023070706524153600_CIT0008","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1038\/s41598-020-66328-8","article-title":"Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20\u00a0years following primary treatment in childhood","volume":"10","author":"Fri\u010d","year":"2020","journal-title":"Sci Rep."},{"issue":"14","key":"2023070706524153600_CIT0009","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1200\/JCO.2008.21.1839","article-title":"Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the childhood cancer survivor study","volume":"27","author":"Green","year":"2009","journal-title":"Am. J.\u00a0Clin. Oncol."},{"key":"2023070706524153600_CIT0010","doi-asserted-by":"crossref","first-page":"1564794","DOI":"10.1155\/2012\/564794","article-title":"Reproductive late effects in female survivors of childhood cancer","volume":"2012","author":"Gnaneswaran","year":"2012","journal-title":"Obstet Gynecol Int."},{"issue":"9","key":"2023070706524153600_CIT0011","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/adc.58.9.722","article-title":"Growth and endocrine function after treatment for medulloblastoma","volume":"58","author":"Brown","year":"1983","journal-title":"Arch Dis Child."},{"issue":"2","key":"2023070706524153600_CIT0012","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-009-9927-z","article-title":"From childhood to adulthood: long-term outcome of medulloblastoma patients. The institut curie experience (1980\u20132000)","volume":"95","author":"Frange","year":"2009","journal-title":"J Neurooncol."},{"issue":"2","key":"2023070706524153600_CIT0013","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/pbc.25274","article-title":"Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk-adapted craniospinal irradiation and adjuvant chemotherapy","volume":"62","author":"DeWire","year":"2015","journal-title":"Pediatric Blood Cancer"},{"issue":"6","key":"2023070706524153600_CIT0014","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/neuonc\/nov302","article-title":"Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma","volume":"18","author":"Eaton","year":"2016","journal-title":"Neuro Oncol"},{"issue":"5","key":"2023070706524153600_CIT0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cen.12815","article-title":"Endocrine sequelae beyond 10\u00a0years in survivors of medulloblastoma","volume":"83","author":"Uday","year":"2015","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"6","key":"2023070706524153600_CIT0016","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1210\/jcem-54-6-1164","article-title":"Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors","volume":"54","author":"Rappaport","year":"1982","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2023070706524153600_CIT0017","first-page":"598","article-title":"Endocrinological late effects of oncologic treatment on survivors of medulloblastoma","volume":"90","author":"Hidalgo\u00a0Santos","year":"2019","journal-title":"Rev Chil Pediatr."},{"issue":"9","key":"2023070706524153600_CIT0018","doi-asserted-by":"crossref","first-page":"e10824","DOI":"10.2196\/10824","article-title":"Fertility among female survivors of childhood, adolescent, and young adult cancer: protocol for two pan-european studies (PanCareLIFE)","volume":"7","author":"van\u00a0den\u00a0Berg","year":"2018","journal-title":"JMIR Res Protoc."},{"issue":"6","key":"2023070706524153600_CIT0019","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/humrep\/deab035","article-title":"Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE)","volume":"36","author":"van\u00a0den\u00a0Berg","year":"2021","journal-title":"Hum Reprod."},{"issue":"7 Suppl","key":"2023070706524153600_CIT0020","first-page":"s176","article-title":"Obesity: definition, comorbidities, causes, and burden","volume":"22","author":"Apovian","year":"2016","journal-title":"Am J Manag Care."},{"issue":"3","key":"2023070706524153600_CIT0021","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2016-2573","article-title":"Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline","volume":"102","author":"Styne","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2023070706524153600_CIT0022","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/pbc.24679","article-title":"The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study","volume":"61","author":"Green","year":"2014","journal-title":"Pediatr Blood Cancer."},{"issue":"3","key":"2023070706524153600_CIT0023","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/humupd\/dmac004","article-title":"Anti-M\u00fcllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review","volume":"28","author":"Anderson","year":"2022","journal-title":"Hum Reprod Update."},{"issue":"10","key":"2023070706524153600_CIT0024","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/0360-3016(86)90318-4","article-title":"Medulloblastoma: the Duke University Medical Center experience","volume":"12","author":"Hershatter","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"16","key":"2023070706524153600_CIT0025","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1002\/cam4.3199","article-title":"Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma","volume":"9","author":"Lee","year":"2020","journal-title":"Cancer Med."},{"issue":"2","key":"2023070706524153600_CIT0026","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11060-022-04049-w","article-title":"Molecular matched targeted therapies for primary b","volume":"159","author":"Luger","year":"2022","journal-title":"J Neurooncol."},{"issue":"7","key":"2023070706524153600_CIT0027","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/jc.2016-3723","article-title":"Premature ovarian insufficiency in childhood cancer survivors: a report from the st. jude lifetime cohort","volume":"102","author":"Chemaitilly","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2023070706524153600_CIT0028","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1470-2045(16)00086-3","article-title":"Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort","volume":"17","author":"Chow","year":"2016","journal-title":"Lancet Oncol."},{"issue":"6","key":"2023070706524153600_CIT0029","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/humupd\/dmaa041","article-title":"Impacts of platinum-based chemotherapy on subsequent testicular function and fertility in boys with cancer","volume":"26","author":"Tian\u00a0En","year":"2020","journal-title":"Hum Reprod Update."},{"issue":"2","key":"2023070706524153600_CIT0030","first-page":"113","article-title":"Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy","volume":"6","author":"Xu","year":"2004","journal-title":"J. Neurooncol"},{"issue":"4","key":"2023070706524153600_CIT0031","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0022-3476(83)80584-8","article-title":"Primary gonadal damage following treatment of brain tumors in childhood","volume":"103","author":"Ahmed","year":"1983","journal-title":"J Pediatr."},{"issue":"5","key":"2023070706524153600_CIT0032","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/adc.63.5.495","article-title":"Gonadal dysfunction after treatment of intracranial tumours","volume":"63","author":"Livesey","year":"1988","journal-title":"Arch Dis Child."},{"issue":"5","key":"2023070706524153600_CIT0033","doi-asserted-by":"crossref","first-page":"e2156","DOI":"10.1210\/clinem\/dgab893","article-title":"High prevalence of early endocrine disorders after childhood brain tumors in a large cohort","volume":"107","author":"Gonz\u00e1lez\u00a0Brice\u00f1o","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2023070706524153600_CIT0034","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mpo.10267","article-title":"Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours","volume":"40","author":"Spoudeas","year":"2003","journal-title":"Med Pediatr Oncol."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noad009\/49288872\/noad009.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/7\/1345\/50836205\/noad009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/7\/1345\/50836205\/noad009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T02:53:53Z","timestamp":1688698433000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/25\/7\/1345\/6986367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,1,12]]},"published-print":{"date-parts":[[2023,7,6]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noad009","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2023,1,12]]}}}